573 related articles for article (PubMed ID: 11181530)
1. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.
Rocca AS; LaGreca J; Kalitsky J; Brubaker PL
Endocrinology; 2001 Mar; 142(3):1148-55. PubMed ID: 11181530
[TBL] [Abstract][Full Text] [Related]
2. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion.
Rocca AS; Brubaker PL
Endocrinology; 1999 Apr; 140(4):1687-94. PubMed ID: 10098504
[TBL] [Abstract][Full Text] [Related]
3. Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes.
Brynes AE; Edwards CM; Jadhav A; Ghatei MA; Bloom SR; Frost GS
Am J Clin Nutr; 2000 Nov; 72(5):1111-8. PubMed ID: 11063437
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects.
Thomsen C; Rasmussen O; Lousen T; Holst JJ; Fenselau S; Schrezenmeir J; Hermansen K
Am J Clin Nutr; 1999 Jun; 69(6):1135-43. PubMed ID: 10357731
[TBL] [Abstract][Full Text] [Related]
5. Effects of an olive oil-enriched diet on plasma GLP-1 concentration and intestinal content, plasma insulin concentration, and glucose tolerance in normal rats.
Prieto PG; Cancelas J; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ
Endocrine; 2005 Mar; 26(2):107-15. PubMed ID: 15888922
[TBL] [Abstract][Full Text] [Related]
6. Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.
Andersen O; Haugaard SB; Holst JJ; Deacon CF; Iversen J; Andersen UB; Nielsen JO; Madsbad S
HIV Med; 2005 Mar; 6(2):91-8. PubMed ID: 15807714
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes.
Thomsen C; Storm H; Holst JJ; Hermansen K
Am J Clin Nutr; 2003 Mar; 77(3):605-11. PubMed ID: 12600850
[TBL] [Abstract][Full Text] [Related]
8. Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.
Vaag AA; Holst JJ; Vølund A; Beck-Nielsen HB
Eur J Endocrinol; 1996 Oct; 135(4):425-32. PubMed ID: 8921824
[TBL] [Abstract][Full Text] [Related]
9. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
10. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
[TBL] [Abstract][Full Text] [Related]
11. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
12. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
Nauck MA; Siemsglüss J; Orskov C; Holst JJ
Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
[TBL] [Abstract][Full Text] [Related]
13. Interaction between specific fatty acids, GLP-1 and insulin secretion in humans.
Beysen C; Karpe F; Fielding BA; Clark A; Levy JC; Frayn KN
Diabetologia; 2002 Nov; 45(11):1533-41. PubMed ID: 12436337
[TBL] [Abstract][Full Text] [Related]
14. The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans.
Mandøe MJ; Hansen KB; Hartmann B; Rehfeld JF; Holst JJ; Hansen HS
Am J Clin Nutr; 2015 Sep; 102(3):548-55. PubMed ID: 26178726
[TBL] [Abstract][Full Text] [Related]
15. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
Cani PD; Neyrinck AM; Maton N; Delzenne NM
Obes Res; 2005 Jun; 13(6):1000-7. PubMed ID: 15976142
[TBL] [Abstract][Full Text] [Related]
16. Effects of dietary fatty acid composition from a high fat meal on satiety.
Kozimor A; Chang H; Cooper JA
Appetite; 2013 Oct; 69():39-45. PubMed ID: 23688821
[TBL] [Abstract][Full Text] [Related]
17. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.
Meier JJ; Nauck MA; Kranz D; Holst JJ; Deacon CF; Gaeckler D; Schmidt WE; Gallwitz B
Diabetes; 2004 Mar; 53(3):654-62. PubMed ID: 14988249
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line.
Brubaker PL; Schloos J; Drucker DJ
Endocrinology; 1998 Oct; 139(10):4108-14. PubMed ID: 9751489
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats.
Anini Y; Hansotia T; Brubaker PL
Endocrinology; 2002 Jun; 143(6):2420-6. PubMed ID: 12021207
[TBL] [Abstract][Full Text] [Related]
20. Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
Carr RD; Larsen MO; Winzell MS; Jelic K; Lindgren O; Deacon CF; Ahrén B
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E779-84. PubMed ID: 18612044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
